Radiology and Oncology (Dec 2017)

A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

  • Tu Chih-Yen,
  • Hsia Te-Chun,
  • Fang Hsin-Yuan,
  • Liang Ji-An,
  • Yang Su-Tso,
  • Li Chia-Chin,
  • Chien Chun-Ru

DOI
https://doi.org/10.1515/raon-2017-0058
Journal volume & issue
Vol. 52, no. 2
pp. 181 – 188

Abstract

Read online

Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC.

Keywords